Aethlon medical announces pricing of $4.5 million public offering

San diego , sept. 4, 2025 /prnewswire/ -- aethlon medical, inc. ("aethlon" or the "company") (nasdaq: aemd), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced the pricing of a public offering of an aggregate of 5,000,000 shares of its common stock (or pre-funded warrants in lieu thereof) and warrants to purchase up to 5,000,000 shares of common stock at a combined public offering price of $0.90 per share (or pre-funded warrant) and accompanying warrant.
AEMD Ratings Summary
AEMD Quant Ranking